Background: Gastroesophageal reflux disease (GERD) may need repeated endoscopy for diagnosis and follow up, this may concern psychological and financial burden on patient. Aim of the work:The aim of our work was to evaluate the benefit of the FSSG as a useful and a practical tool for diagnosing of GERD patients compared to the endoscopic results. This was mainly to avoid repeated uses of endoscopy for diagnosis and may reduce the medical costs and save the patients time Patients & Methods: This study was carried out at and endoscopy unit during the period from June 2015 to December 2015.The subjects were 131 Egyptian patients aged ≥18 year (mean 46.3± 16.8 year; male/female ratio 1.8/1) who presented with symptoms of heartburn, regurgitation and epigastric pain or discomfort. They were scheduled for esophagogastroduodenoscopy. It was done after approval of Local Ethics Committee and patient's consent was obtained. Pre-endoscopy Procedure: Our study depends on a simplified questionnaire for evaluation of the symptoms of GERD called FSSG (Frequency Scale for Symptoms of GERD) which consists of 12 questions; all must be answered by all subjects Endoscopy Procedure: All subjects underwent esophagogastroduodenoscopy. The results of endoscopy were classified and graded according to Los Angeles classification into GERD A, B and C according to the severity of the endoscopic findings. After that the final endoscopic diagnosis was compared to the predicted diagnosis resulting from the Regression model and Equation. Results: Based on the endoscopic findings, the number of patients with GERD Los Angeles Class A, B and C was 18.3, 15.3 and 6.9 % respectively. Clinical obesity patients were 3 distributed as duodenal ulcer (DU) = 2 and GERD B = 1 patient. Overweight patients were 58 distributed as gastric ulcer (GU) = 13, DU = 7, functional dyspepsia (NUD) = 14, GERD A = 8, GERD B = 8 and GERD C = 8 patients. Normal weight patients were 63 distributed as GU = 14, DU = 11, NUD = 11, GERD A = 16, GERD B = 10 and GERD C = 1 patients. Underweight patients were 7 distributed as DU = 1, GU = 2, NUD = 3, GERD A = 0, GERD B = 1 and GERD C = 0 patients. Usage of the FSSG questionnaire with Regression Model help us to predict strongly GERD A by 95.8%, also GERD B by 95% and weakly predict DU by 81.8%, GERD C by 77.7%, GU by 60.7% and NUD by 50%.Conclusion: Noninvasive assessment tool FSSG questionnaire was useful for objective evaluation of symptoms in GERD patients and avoid repeated endoscopic examination which is undesirable in terms of medical costs and the burden on the patient and save our developing country efforts and resources.
INTRODUCTION
condition in which the liquid content of the stomach regurgitates (backs up or refluxes) into the esophagus defined as gastroesophageal reflux disease and commonly referred to GERD or acid reflux. Although visible signs of inflammation occur in a minority of patients the liquid can inflame and damage the lining of the esophagus [1] . The regurgitated liquid usually contains acid and pepsin that are secreted by the stomach and may contain bile that has backed-up into the stomach from the duodenum. Acid is believed to be the most injurious component of the refluxed liquid.
The role of pepsin and bile in the production of esophageal inflammation and damage is not as clear as the role of acid [2] .
Despite this, a cure for the disease has remained elusive and the natural history of the disease remains uncertain. For example, some complications such as esophageal strictures have decreased in prevalence in some countries but the most troubling of the complications of reflux disease (esophageal adenocarcinoma) continues to increase at an alarming rate [2] .
Because limited long-term data on natural history are available prior to the widespread availability of acid inhibitory A agents, the natural history of reflux disease remains uncertain [3] . Prior use of nonsteroidal anti-inflammatory drugs smoking, excess body weight and gastrointestinal and cardiac conditions were associated with increased diagnosis of gastro-esophageal reflux disease [4] . A higher frequency of symptoms like heartburn, regurgitation and epigastric pain (greater than 3 times per week) and a long duration of symptoms further increased the risk of GERD [5] .
Less is known about spontaneous exacerbations and remissions of the disease. Indirect evidence does suggest that some patients may have troublesome symptoms intermittently [6] .
Gastroesophageal reflux disease may need repeated endoscopy for diagnosis and follow up, this may concern psychological and financial burden on patient. So we need a simple, accurate and easy tool to diagnose and follow up these patients without using endoscopy. Upper GI endoscopy is to identify esophageal erosions, the hall-mark feature of erosive reflux disease. New studies though document that up to 70% of patients with esophageal symptoms have normal endoscopic findings in the esophagus [7] . Esophageal reflux monitoring is the gold standard used to quantify esophageal acid exposure in patients with reflux symptoms and normal endoscopic findings, part of preoperative evaluation in patients planned for anti-reflux and inpatients with persistent reflux symptoms despite acid suppressive therapy [1] . In clinical gastroesophageal reflux and dyspepsia trials, symptoms evaluation by questionnaires have been recommended as the primary outcome measures. Questionnaires should have proven reliability, validity, and responsiveness, and may assess the frequency and/or severity of dyspepsia symptoms [8] .
Unidimensional questionnaires contain items concerning a single aspect of dyspepsia, such as symptom severity, whereas multidimensional instruments assess multiple aspects of the condition, usually symptoms and quality of life. Global scales use a single question to rate the overall severity of the condition. Questionnaires must undergo prior validation for three characteristicsreliability, validity, and responsiveness before they are used in clinical trials [9] .
Reliability is the ability of an instrument to give the same result in response to the same clinical condition on different occasions [10] . Validity refers to whether the questionnaire is actually measuring what it is designed to measure [10] . Responsiveness describes whether the questionnaire is capable of detecting changes in a condition over time, which might reflect therapeutic effects [10] .
The aim of our work is to evaluate the benefit of the FSSG as a useful and a practical tool for diagnosing of GERD patients compared to the endoscopic results. This is mainly to avoid repeated uses of endoscopy for diagnosis that may reduce the medical costs and save the patients time, and money in our country.
PATIENTS & METHODS This study was carried out at Zagazig University, Faculty of Medicine, Internal Medicine Department, Gastroenterology and endoscopy unit during period from June 2015 to December 2015.The subjects were 131 Egyptian patients aged ≥18 year (mean 46.3± 16.8 year; male/female 1.8/1) who presented with symptoms of heartburn, regurgitation and epigastric pain or discomfort. They were scheduled for esophagogastroduodenoscopy. It was done after approval of Local Ethics Committee and patient's consent was obtained.
Inclusion criteria: Patients presented with symptoms of heartburn, regurgitation and/or epigastric pain or discomfort: without any exclusion as regarding for age, sex, smoking habits, drug intake, pregnancy and Body Mass Index (BMI). BMI= weight (kg)/ (height (M)) 2. Less than 20 = underweight, 20-25 = normal, 25-30 = overweight an more than 30 = clinical obesity [11] . Clinical examination routine laboratory investigations were done including complete blood picture, liver function tests and kidney function tests.
Methods: I-Pre-endoscopy Procedure:
Our study depends on a simplified questionnaire for evaluation of the symptoms of GERD called FSSG (Frequency Scale for Symptoms of GERD) which consists of 12 questions; all must be answered by all subjects. As shown in (table I) .  Total score were given to each patient.
II-Endoscopy Procedure:
-All subjects underwent esophagogastroduodenoscopy.
The results of endoscopy were classified and graded according to Los Angeles classification into GERD A, B and C according to the severity of the endoscopic findings [13].
-Other endoscopic findings were gastric ulcer (GU), duodenal ulcer (DU), functional dyspepsia (NUD).
-After that the final endoscopic diagnosis was compared to the predicted diagnosis resulting from the Regression model and Equation.
Statistical Analysis:
Data were analyzed according to computerized statistical program SPSS (version 18, SPSS Inc., Chicago, IL, USA).The aim of this analysis is to predict the diagnosis according to the score of the questionnaire previously obtained during history taking prior to upper GI endoscopy. Regression model (Y= α + βX) is designed to achieve this aim statistically. Where: Y = dependent variable (diagnosis), α = regression intercept = constant β = regression coefficient = slope, X = independent variable = score -Code number was assigned to each predicted disease from 1 to 6 according to the ascending results of total score of the questionnaire as follow: 
Results:
The number of the patients in the current study with heartburn, regurgitation, epigastric pain and discomfort was 131, of which the male patients were 64.9%, while the female patients were 35.1%. The age of the patients ranged from 18 to 83 years. The body mass index of the patients was 24.2±3.2. NUD  GU  DU  GERD A  GERD B  GERD C   Smoking  11  15  13  13  9  7   Pregnancy  4  1  0  1  0  0  Drugs  8  13  9  7  8  1 Drug like Non-steroidal anti-inflammatory drugs (NSAIDs), cortisone, bronchial asthma drugs There was no significant difference among different endoscopic findings in different ages of patients (P=0.49). [15] . The studies of clinical manifestations of GERD have led to the development of the frequency scale for the symptoms of GERD (FSSG) questionnaire that scores the frequency at which patients experience the complaints, and has been shown to be useful in the diagnosis and follow up of GERD [12] . Over use of upper endoscopy contributes to higher health care costs without improving patient outcomes, so for identification of GERD symptoms in every day clinical practice, the questionnaire are developed and used as FSSG [12] . The questions related to 12 symptoms that the patients with GERD complain of most not only heart burn and acid taste but also dyspeptic symptoms such as heavy stomach and feeling full quickly [16] . In our study, there is significant frequency of heartburn, regurgitation and epigastric pain or discomfort in male than female and older age than younger age and this in agreement of the findings of El-Serag and Sonnenberg (1997) [17] .
Our study revealed a tendency of heartburn, regurgitation and epigastric pain or discomfort in smokers than nonsmoker. But the result of other study showed controversial associations. Nevertheless, smoking is not considered a major risk factor for GERD despite the impact if both smoking and nicotine on major GERD pathophysiologic factor [18] . We found that there was significant frequency of heartburn, regurgitation and epigastric pain or discomfort in overweight and obese patients than normal weight. El Serag (2008) studied the role of obesity in GERD related disorders. The abdominal obesity promoted GERD by elevating intraabdominal pressure, which increases reflux and the hiatus hernia development [19] .In the
